Overview (04 Nov 2026)
Rubicon Research Ltd
RUBICON
INE506V01022
Pharmaceuticals
0.25
Prev. Close
Previous Close
1716.3
Current Close
1716.55
Current High
1728.9
Current Low
1706.95
52 Week High
1896.15
52 Week Low
610.3
Resistance 1
1727.99
Resistance 2
1739.42
Support 1
1706.04
Support 2
1684.09
Std Deviation
6.91%
DMA 200
1214.85
DMA 50
1661.66
DMA 20
1545.47
Fundamentals and Ratios
Standalone
Trailing EPS
11.83
Forwad EPS
15.36
Trailing P/E
145.1
Forward P/E
111.75
PEG Ratio
Mkt. Cap (Cr)
Market Cap (Cr)
28388.78
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25FY25-26
Revenue427.73389.88301.71336.471306.08
Other Income2.413.584.301.5110.83
Total Income430.14393.46306.01337.981316.91
Interest6.015.407.519.2130.96
Expenditure-319.48-299.27-256.48-276.35-1064.14
PBDT0.000.000.000.000.00
Depreciation-10.57-10.17-9.51-9.78-37.75
PBT110.6694.1949.5361.63252.78
Tax-28.21-24.17-12.35-15.82-64.61
Equity16.5416.510.0015.4416.51
OPM25.7323.9416.4218.2319.19
Net Profit82.4570.0237.1845.81188.17
NPM19.1717.812.3213.5514.29
EPS4.994.252.282.9711.83
Consolidated
TypeJun-26Mar-26Dec-25Sep-25FY25-26
Revenue534.34513.92475.53412.021753.96
Other Income5.682.613.790.707.73
Total Income540.02516.53479.32412.721761.68
Interest9.2910.369.7711.4242.17
Expenditure-429.65-417.84-388.73-341.01-1441.15
PBDT0.000.000.000.000.00
Depreciation-15.14-12.27-11.55-11.87-45.26
PBT110.3798.6990.5971.71320.53
Tax-25.59-21.90-17.79-17.85-73.80
Equity16.5416.510.0015.4416.51
OPM20.4419.1118.9017.3718.19
Net Profit84.7876.7972.853.85246.74
NPM15.714.8715.1913.0514.01
EPS5.134.664.463.4915.52
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2026Final Dividend1.50Final Dividend - Rs. - 1.500007 Aug 2026
Bonus
Split

Mutual Fund Holddings